SlideShare une entreprise Scribd logo
1  sur  9
Crystals and IP Linda McCausland Head of Physical Sciences April 2011
Overview ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Issues or Advantages? Purity Yield Crystal size Solids handling Solubility Polymorphism Crystal shape Scale-up Solvates & Hydrates Isolation Dissolution
Protecting Invention ,[object Object],[object Object]
IP services ,[object Object],[object Object]
IP services continued… ,[object Object],[object Object],[object Object],[object Object]
About us ,[object Object]
Experience ,[object Object]
Technical consultancy & support ,[object Object]

Contenu connexe

En vedette

Rapidd™
Rapidd™Rapidd™
Rapidd™ejmckee
 
Almac Protein Ligation Technology Webinar Presentation 12 09-2012
Almac Protein Ligation Technology Webinar Presentation 12 09-2012Almac Protein Ligation Technology Webinar Presentation 12 09-2012
Almac Protein Ligation Technology Webinar Presentation 12 09-2012Susan1Beattie
 
Dr.V.chandrasekharan
Dr.V.chandrasekharanDr.V.chandrasekharan
Dr.V.chandrasekharanDipak Shetty
 
Solid State Capabilities
Solid State CapabilitiesSolid State Capabilities
Solid State Capabilitiesejmckee
 
Polymorphism: opportunity or problem?
Polymorphism: opportunity or problem?Polymorphism: opportunity or problem?
Polymorphism: opportunity or problem?Covello Luca
 
Cryst Dev Case Study Dec 2011
Cryst Dev Case Study Dec 2011Cryst Dev Case Study Dec 2011
Cryst Dev Case Study Dec 2011Linda_Mccausland
 
Polymorphism and crystallisation : The mysterious phenomenon
Polymorphism and crystallisation : The mysterious phenomenonPolymorphism and crystallisation : The mysterious phenomenon
Polymorphism and crystallisation : The mysterious phenomenonMadhulika Harde
 
4016 solid state analysis
4016 solid state analysis4016 solid state analysis
4016 solid state analysisPatel Parth
 
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)Mark_Sullivan
 
X-ray Powder Diffraction:exposing the bare bones of solid forms
X-ray Powder Diffraction:exposing the bare bones of solid formsX-ray Powder Diffraction:exposing the bare bones of solid forms
X-ray Powder Diffraction:exposing the bare bones of solid formsLinda_Mccausland
 
Polymorph Quantitation
Polymorph QuantitationPolymorph Quantitation
Polymorph Quantitationreychemist
 
Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...
Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...
Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...Susan1Beattie
 
Pharmaceutical Solid Form
Pharmaceutical Solid FormPharmaceutical Solid Form
Pharmaceutical Solid FormSimon Curtis
 
Seminar on polymorphism
Seminar on polymorphismSeminar on polymorphism
Seminar on polymorphism023henil
 

En vedette (16)

Rapidd™
Rapidd™Rapidd™
Rapidd™
 
Almac Protein Ligation Technology Webinar Presentation 12 09-2012
Almac Protein Ligation Technology Webinar Presentation 12 09-2012Almac Protein Ligation Technology Webinar Presentation 12 09-2012
Almac Protein Ligation Technology Webinar Presentation 12 09-2012
 
Dr.V.chandrasekharan
Dr.V.chandrasekharanDr.V.chandrasekharan
Dr.V.chandrasekharan
 
Solid State Capabilities
Solid State CapabilitiesSolid State Capabilities
Solid State Capabilities
 
Polymorphism: opportunity or problem?
Polymorphism: opportunity or problem?Polymorphism: opportunity or problem?
Polymorphism: opportunity or problem?
 
Cryst Dev Case Study Dec 2011
Cryst Dev Case Study Dec 2011Cryst Dev Case Study Dec 2011
Cryst Dev Case Study Dec 2011
 
Polymorphism and crystallisation : The mysterious phenomenon
Polymorphism and crystallisation : The mysterious phenomenonPolymorphism and crystallisation : The mysterious phenomenon
Polymorphism and crystallisation : The mysterious phenomenon
 
4016 solid state analysis
4016 solid state analysis4016 solid state analysis
4016 solid state analysis
 
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
 
X-ray Powder Diffraction:exposing the bare bones of solid forms
X-ray Powder Diffraction:exposing the bare bones of solid formsX-ray Powder Diffraction:exposing the bare bones of solid forms
X-ray Powder Diffraction:exposing the bare bones of solid forms
 
Polymorph Quantitation
Polymorph QuantitationPolymorph Quantitation
Polymorph Quantitation
 
Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...
Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...
Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...
 
Pharmaceutical Solid Form
Pharmaceutical Solid FormPharmaceutical Solid Form
Pharmaceutical Solid Form
 
Quality by Design
Quality by DesignQuality by Design
Quality by Design
 
Seminar on polymorphism
Seminar on polymorphismSeminar on polymorphism
Seminar on polymorphism
 
Polymorphism
PolymorphismPolymorphism
Polymorphism
 

Similaire à Crystals And IP April 2011

Origiin Corporate Presentation 01
Origiin Corporate Presentation 01Origiin Corporate Presentation 01
Origiin Corporate Presentation 01Anita Kalia
 
Competitive landsape by Clarivate Analytics
Competitive landsape by Clarivate AnalyticsCompetitive landsape by Clarivate Analytics
Competitive landsape by Clarivate AnalyticsSam Nixon
 
Kemxtree Presentation
Kemxtree PresentationKemxtree Presentation
Kemxtree Presentationguest44c9cb9c
 
Alyante Introduction Presentation
Alyante Introduction PresentationAlyante Introduction Presentation
Alyante Introduction PresentationWockhardt Limited
 
Importance Of Patents In The Life Sciences Industry
Importance Of Patents In The Life Sciences IndustryImportance Of Patents In The Life Sciences Industry
Importance Of Patents In The Life Sciences Industrybatane
 
Microneedles for drug delivery patent landscape 2020 flyer
Microneedles for drug delivery patent landscape 2020 flyerMicroneedles for drug delivery patent landscape 2020 flyer
Microneedles for drug delivery patent landscape 2020 flyerKnowmade
 
Short introduction to Imperial Innovations
Short introduction to Imperial InnovationsShort introduction to Imperial Innovations
Short introduction to Imperial InnovationsImperialInnova
 
Food Nutraceutical Packaging Chemistry Presentation
Food Nutraceutical Packaging Chemistry PresentationFood Nutraceutical Packaging Chemistry Presentation
Food Nutraceutical Packaging Chemistry Presentationwzawhat
 
Health and life sciences Webinar 25th September 2013
Health and life sciences Webinar 25th September 2013Health and life sciences Webinar 25th September 2013
Health and life sciences Webinar 25th September 2013CambridgeIP Ltd
 
Methods to improve Freedom to Operate analysis
Methods to improve Freedom to Operate analysisMethods to improve Freedom to Operate analysis
Methods to improve Freedom to Operate analysisDauverC
 
Capsule endoscopy Patent Landscape 2014 Sample
Capsule endoscopy Patent Landscape 2014 SampleCapsule endoscopy Patent Landscape 2014 Sample
Capsule endoscopy Patent Landscape 2014 SampleKnowmade
 
Biomedical Photoacoustic Imaging Patent Landscape Sample
Biomedical Photoacoustic Imaging Patent Landscape SampleBiomedical Photoacoustic Imaging Patent Landscape Sample
Biomedical Photoacoustic Imaging Patent Landscape SampleKnowmade
 
ENSafrica Pharma - Biotech IP Capability Statement 2016
ENSafrica Pharma - Biotech IP Capability Statement 2016 ENSafrica Pharma - Biotech IP Capability Statement 2016
ENSafrica Pharma - Biotech IP Capability Statement 2016 Joanne van Harmelen
 
Workshop 2 - Legal Concerns (Steve Davey) Cullens Brochure
Workshop 2 - Legal Concerns (Steve Davey) Cullens BrochureWorkshop 2 - Legal Concerns (Steve Davey) Cullens Brochure
Workshop 2 - Legal Concerns (Steve Davey) Cullens BrochureAngela Li
 
Overcoming Organizational Barriers
Overcoming Organizational BarriersOvercoming Organizational Barriers
Overcoming Organizational BarriersKapost
 
What to know if it is your first rodeo in patent monetization.pptx
What to know if it is your first rodeo in patent monetization.pptxWhat to know if it is your first rodeo in patent monetization.pptx
What to know if it is your first rodeo in patent monetization.pptxturo6
 

Similaire à Crystals And IP April 2011 (20)

Origiin Corporate Presentation 01
Origiin Corporate Presentation 01Origiin Corporate Presentation 01
Origiin Corporate Presentation 01
 
Competitive landsape by Clarivate Analytics
Competitive landsape by Clarivate AnalyticsCompetitive landsape by Clarivate Analytics
Competitive landsape by Clarivate Analytics
 
Kemxtree Presentation
Kemxtree PresentationKemxtree Presentation
Kemxtree Presentation
 
Alyante Introduction Presentation
Alyante Introduction PresentationAlyante Introduction Presentation
Alyante Introduction Presentation
 
Dnal 1
Dnal 1Dnal 1
Dnal 1
 
Importance Of Patents In The Life Sciences Industry
Importance Of Patents In The Life Sciences IndustryImportance Of Patents In The Life Sciences Industry
Importance Of Patents In The Life Sciences Industry
 
Microneedles for drug delivery patent landscape 2020 flyer
Microneedles for drug delivery patent landscape 2020 flyerMicroneedles for drug delivery patent landscape 2020 flyer
Microneedles for drug delivery patent landscape 2020 flyer
 
Short introduction to Imperial Innovations
Short introduction to Imperial InnovationsShort introduction to Imperial Innovations
Short introduction to Imperial Innovations
 
Food Nutraceutical Packaging Chemistry Presentation
Food Nutraceutical Packaging Chemistry PresentationFood Nutraceutical Packaging Chemistry Presentation
Food Nutraceutical Packaging Chemistry Presentation
 
Health and life sciences Webinar 25th September 2013
Health and life sciences Webinar 25th September 2013Health and life sciences Webinar 25th September 2013
Health and life sciences Webinar 25th September 2013
 
Methods to improve Freedom to Operate analysis
Methods to improve Freedom to Operate analysisMethods to improve Freedom to Operate analysis
Methods to improve Freedom to Operate analysis
 
Polymorph patents
Polymorph patentsPolymorph patents
Polymorph patents
 
IPR Collateral 4bridge
IPR Collateral 4bridgeIPR Collateral 4bridge
IPR Collateral 4bridge
 
Capsule endoscopy Patent Landscape 2014 Sample
Capsule endoscopy Patent Landscape 2014 SampleCapsule endoscopy Patent Landscape 2014 Sample
Capsule endoscopy Patent Landscape 2014 Sample
 
Biomedical Photoacoustic Imaging Patent Landscape Sample
Biomedical Photoacoustic Imaging Patent Landscape SampleBiomedical Photoacoustic Imaging Patent Landscape Sample
Biomedical Photoacoustic Imaging Patent Landscape Sample
 
ENSafrica Pharma - Biotech IP Capability Statement 2016
ENSafrica Pharma - Biotech IP Capability Statement 2016 ENSafrica Pharma - Biotech IP Capability Statement 2016
ENSafrica Pharma - Biotech IP Capability Statement 2016
 
Workshop 2 - Legal Concerns (Steve Davey) Cullens Brochure
Workshop 2 - Legal Concerns (Steve Davey) Cullens BrochureWorkshop 2 - Legal Concerns (Steve Davey) Cullens Brochure
Workshop 2 - Legal Concerns (Steve Davey) Cullens Brochure
 
Nutriband Inc. 2021 Deck
Nutriband Inc. 2021 DeckNutriband Inc. 2021 Deck
Nutriband Inc. 2021 Deck
 
Overcoming Organizational Barriers
Overcoming Organizational BarriersOvercoming Organizational Barriers
Overcoming Organizational Barriers
 
What to know if it is your first rodeo in patent monetization.pptx
What to know if it is your first rodeo in patent monetization.pptxWhat to know if it is your first rodeo in patent monetization.pptx
What to know if it is your first rodeo in patent monetization.pptx
 

Crystals And IP April 2011

  • 1. Crystals and IP Linda McCausland Head of Physical Sciences April 2011
  • 2.
  • 3. Issues or Advantages? Purity Yield Crystal size Solids handling Solubility Polymorphism Crystal shape Scale-up Solvates & Hydrates Isolation Dissolution
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.